ADIPOQ and heart failure: We conducted the first one-sample Mendelian randomization study on the association between plasma adiponectin with the risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction facilitating exploration of non-linear effects and subgroup associations with no evidence of a causal effect.